-transparent.png){kind=logo}
It is well known, that the quality standards of the various pharmacopoeias are based on certain procedures of synthesis or preparation concerning the drugs. Altering the manufacturing methods or importing these drugs from different producers, it may arise that the examined substance will formally come up to the quality directions of the pharmacopoeia agreed upon, but will contain possible, critical contaminations which are beyond the pharmacopoeia directions of examinations.
Related Publications
J Richter, and
H Sachweh, and
M Wagler
January 1965,
Pharmazeutische Praxis,
J Richter, and
H Sachweh, and
M Wagler
January 1965,
Pharmazeutische Praxis,
J Richter, and
H Sachweh, and
M Wagler
June 1971,
Pharmaceutica acta Helvetiae,
J Richter, and
H Sachweh, and
M Wagler
September 2019,
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
J Richter, and
H Sachweh, and
M Wagler
January 1975,
Ceskoslovenska farmacie,
J Richter, and
H Sachweh, and
M Wagler
April 1986,
Die Pharmazie,
J Richter, and
H Sachweh, and
M Wagler
December 1988,
Die Pharmazie,
J Richter, and
H Sachweh, and
M Wagler
January 1987,
Bulletin de l'Academie nationale de medecine,
J Richter, and
H Sachweh, and
M Wagler
January 2004,
Die Pharmazie,
J Richter, and
H Sachweh, and
M Wagler
January 1962,
Farmatsevtychnyi zhurnal,
